SCHEMBL669995

SCHEMBL669995

CCCCCCCC/C=C\CCCCCCCCOCC(N)C(O)CCCCCCCCCCCCCCC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.50
HTT P42858 2/20 0.50
SPHK1 Q9NYA1 2/20 0.50
GMNN O75496 1/20 0.50
LMNA P02545 1/20 0.50
POLB P06746 1/20 0.50
THPO P40225 1/20 0.50
MTOR P42345 1/20 0.50
BLM P54132 1/20 0.50
KDM4E B2RXH2 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
MAPT P10636 1/20 0.50
CETP P11597 1/20 0.50
UBE2N P61088 1/20 0.50
P2RY10 O00398 2/20 0.49
LPAR1 Q92633 2/20 0.49
LPAR3 Q9UBY5 2/20 0.49
USP2 O75604 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL898772 0.96 TRPV1 (0.49) CYP2D6SPHK1GMNNLMNAPOLB
SCHEMBL2728416 0.91 SPHK1 (0.59) CYP2D6HTTSPHK1GMNNLMNA
SCHEMBL2728753 0.91 SPHK1 (0.59) CYP2D6HTTSPHK1GMNNLMNA
SCHEMBL5798415 0.91 SPHK1 (0.59) CYP2D6HTTSPHK1GMNNLMNA
SCHEMBL2727038 0.91 SPHK1 (0.59) CYP2D6HTTSPHK1GMNNLMNA
SCHEMBL26305201 0.82 LPAR1 (0.49) HTTSPHK1P2RY10LPAR1LPAR3
SCHEMBL27544781 0.81 HTT (0.53) CYP2D6HTTSPHK1GMNNLMNA
SCHEMBL10060730 0.81 USP2 (0.59) HTTCYP1A2CYP3A4P2RY10LPAR1
SCHEMBL10526311 0.81 CYP2D6 (0.59) CYP2D6HTTSPHK1GMNNLMNA
SCHEMBL312332 0.81 MEN1 (0.65) CYP2D6HTTSPHK1GMNNLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106063768-A 2,3 dihydroxypropyl dodecylates are for treating the purposes of seborrheic dermatitis 皮埃尔·法布尔皮肤化妆品公司 2016-11-02 CN disclosed
EP-2632424-A1 COSMETIC COMPOSITION COMPRISING A FATTY-CHAIN ALKOXYSILANE AND A CATIONIC OR NONIONIC SURFACTANT. L'Oréal (FR) 2013-09-04 EP disclosed
EP-2632425-A1 COSMETIC COMPOSITION COMPRISING A FATTY-CHAIN ALKOXYSILANE, AN ANIONIC SURFACTANT AND A NONIONIC, AMPHOTERIC OR ZWITTERIONIC SURFACTANT L'Oréal (FR) 2013-09-04 EP disclosed
EP-2632426-A1 COSMETIC COMPOSITION COMPRISING A FATTY-CHAIN ALKOXYSILANE AND A CATIONIC POLYMER L'Oréal (FR) 2013-09-04 EP disclosed
EP-2621465-A2 PROCESS FOR TREATING KERATIN FIBRES USING AT LEAST ONE SULFUREOUS REDUCING AGENT, AT LEAST ONE CATIONIC POLYMER AND AT LEAST ONE MERCAPTOSILOXANE L'Oréal (FR) 2013-08-07 EP disclosed
CN-102781415-A Use of 2, 3-dihydroxypropyl dodecanoate for treating seborrheic dermatitis FABRE PIERRE DERMO COSMETIQUE 2012-11-14 CN disclosed
WO-2012117340-A1 METHOD FOR THE COSMETIC TREATMENT OF SKIN REDNESS L'OREAL (FR) 2012-09-07 WO disclosed
WO-2012055811-A1 COSMETIC COMPOSITION COMPRISING A FATTY-CHAIN ALKOXYSILANE AND A CATIONIC OR NONIONIC SURFACTANT. L'OREAL (FR) 2012-05-03 WO disclosed
WO-2012055809-A1 COSMETIC COMPOSITION COMPRISING A FATTY-CHAIN ALKOXYSILANE, AN ANIONIC SURFACTANT AND A NONIONIC, AMPHOTERIC OR ZWITTERIONIC SURFACTANT L'OREAL (FR) 2012-05-03 WO disclosed
WO-2012055807-A1 COSMETIC COMPOSITION COMPRISING A FATTY-CHAIN ALKOXYSILANE AND A CATIONIC POLYMER L'OREAL (FR) 2012-05-03 WO disclosed
WO-2012042019-A2 PROCESS FOR TREATING KERATIN FIBRES USING AT LEAST ONE SULFUREOUS REDUCING AGENT, AT LEAST ONE CATIONIC POLYMER AND AT LEAST ONE MERCAPTOSILOXANE. L'OREAL (FR) 2012-04-05 WO disclosed
WO-2012022899-A2 METHOD FOR REDUCING POST-REACTIVE HYPERPIGMENTATION L'OREAL (FR) 2012-02-23 WO disclosed
US-5650166-A LIPID VESICLES FOR SKIN TREATMENT L'OREAL (FR) 1997-07-22 US disclosed